RAPLIA Trademark

Trademark Overview

On Thursday, August 12, 2010, a trademark application was filed for RAPLIA with the United States Patent and Trademark Office. The USPTO has given the RAPLIA trademark a serial number of 85105909. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 28, 2014. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The RAPLIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical antiviral preparation
raplia

General Information

Serial Number85105909
Word MarkRAPLIA
Filing DateThursday, August 12, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 28, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2011

Trademark Statements

Goods and ServicesPharmaceutical antiviral preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham, AL 352441879
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 352441879

Trademark Events

Event DateEvent Description
Monday, April 28, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 28, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2013EXTENSION 5 GRANTED
Thursday, September 19, 2013EXTENSION 5 FILED
Thursday, September 19, 2013TEAS EXTENSION RECEIVED
Saturday, March 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 22, 2013EXTENSION 4 GRANTED
Wednesday, March 20, 2013EXTENSION 4 FILED
Wednesday, March 20, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2012EXTENSION 3 GRANTED
Thursday, September 20, 2012EXTENSION 3 FILED
Thursday, September 20, 2012TEAS EXTENSION RECEIVED
Wednesday, April 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 10, 2012EXTENSION 2 GRANTED
Monday, March 19, 2012EXTENSION 2 FILED
Tuesday, April 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 19, 2012TEAS EXTENSION RECEIVED
Saturday, September 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2011EXTENSION 1 GRANTED
Thursday, September 15, 2011EXTENSION 1 FILED
Thursday, September 15, 2011TEAS EXTENSION RECEIVED
Tuesday, March 22, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 22, 2010ASSIGNED TO LIE
Wednesday, December 1, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 30, 2010ASSIGNED TO EXAMINER
Tuesday, August 17, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 16, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

raplia preparation antiviral pharmaceutical